Literature DB >> 2453397

Heterogeneity of antimitochondrial antibodies with the M2-M4 pattern by immunofluorescence as assessed by Western immunoblotting and enzyme linked immunosorbent assay.

M Fusconi1, I Ghadiminejad, F B Bianchi, H Baum, G F Bottazzo, E Pisi.   

Abstract

Seventy seven sera with antimitochondrial antibody exhibiting the M2-M4 pattern in immunofluorescence (56 from primary biliary cirrhosis (PBC), 21 from non-primary biliary cirrhosis patients) were studied by the combined use of Western immunoblotting with beef heart mitochondria and an enzyme linked immunosorbent assay (ELISA) with beef heart submitochondrial particles. Forty seven sera (10 without autoantibodies and 37 with different auto-antibodies) were included as controls. By immunoblotting, seven mitochondrial peptides reacting with antimitochondrial antibody positive sera were detected. These were of molecular weight 74 kD, 58 kD, 55 kD, 52 kD, 51 kD, 46 kD, and 43 kD. All primary biliary cirrhosis sera and 71% of antimitochondrial antibody-positive non-primary biliary cirrhosis sera reacted with one or more of these peptides, while none of the 47 antimitochondrial antibody negative sera reacted in immunoblotting. The 74 kD band was the most frequently detected (84% of primary biliary cirrhosis and 57% of non-primary biliary cirrhosis cases). All the primary biliary cirrhosis sera which failed to react with this peptide, showed a positive reaction with that of molecular weight 52 kD. 67/77 (87%) immunofluorescence antimitochondrial antibody positive sera reacted in the ELISA test (93% of primary biliary cirrhosis and 71% of non-primary biliary cirrhosis cases). All the 47 immunofluorescence antimitochondrial antibody negative sera were confirmed negative by ELISA. The ELISA values correlated with the immunofluorescence titres (p less than 0.05). By comparison of the results obtained by these two techniques, it emerged that the ELISA test (using our preparation of submitochondrial particles) was not able to detect the antibody directed against the mitochondrial peptide of 52 kD, which thus seems to be different from the other specificities.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2453397      PMCID: PMC1433536          DOI: 10.1136/gut.29.4.440

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

1.  A new pattern of non-organ- and non-species-specific anti-organelle antibody detected by immunofluorescence: the mitochondrial antibody number 5.

Authors:  M T Labro; M C Andrieu; M Weber; J C Homberg
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

2.  Specificities and characteristics of mitochondrial protein antigens assessed by enzyme linked immunosorbent assay for anti-mitochondrial antibodies. Relationship to immunofluorescent and precipitating antibodies.

Authors:  R C Gupta
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

3.  Characterization and clinical relevance of a new complement-fixing antibody--anti-M8--in patients with primary biliary cirrhosis.

Authors:  P Weber; J Brenner; E Stechemesser; R Klein; U Weckenmann; G Klöppel; M Kirchhof; V Fintelmann; P A Berg
Journal:  Hepatology       Date:  1986 Jul-Aug       Impact factor: 17.425

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Serological classification of chronic cholestatic liver disease by the use of two different types of antimitochondrial antibodies.

Authors:  P A Berg; K H Wiedmann; T Sayers; G Klöppel; H Lindner
Journal:  Lancet       Date:  1980 Dec 20-27       Impact factor: 79.321

Review 6.  The PBC-specific antigen.

Authors:  H Baum; C Palmer
Journal:  Mol Aspects Med       Date:  1985

7.  A new antimitochondria antibody (anti-M6) in iproniazid-induced hepatitis.

Authors:  J C Homberg; N Stelly; I Andreis; N Abuaf; F Saadoun; J Andre
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

8.  What does the antimitochondrial antibody mean?

Authors:  D R Triger; C A Charlton; A M Ward
Journal:  Gut       Date:  1982-10       Impact factor: 23.059

9.  Reactivities and clinical relevance of antimitochondrial antibodies to four mitochondrial inner membrane proteins in sera of patients with primary biliary cirrhosis.

Authors:  H Ishii; K Saifuku; T Namihisa
Journal:  Hepatology       Date:  1987 Jan-Feb       Impact factor: 17.425

10.  Is mitochondrial antibody diagnostic of primary biliary cirrhosis?

Authors:  L E Munoz; H C Thomas; P J Scheuer; D Doniach; S Sherlock
Journal:  Gut       Date:  1981-02       Impact factor: 23.059

View more
  6 in total

Review 1.  Primary biliary cirrhosis: nature of autoantigens.

Authors:  M F Bassendine; S J Yeaman
Journal:  Springer Semin Immunopathol       Date:  1990

Review 2.  Mitochondrial antigens and antibodies in primary biliary cirrhosis.

Authors:  P Butler; F Valle; A K Burroughs
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

Review 3.  Primary biliary cirrhosis: considerations on pathogenesis based on identification of the M2 autoantigens.

Authors:  I R Mackay; M E Gershwin
Journal:  Springer Semin Immunopathol       Date:  1990

4.  Antimitochondrial autoantibodies in anti-glomerular basement membrane disease.

Authors:  J B Marriott; D B Oliveira
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

5.  Anti-nuclear antibodies of primary biliary cirrhosis recognize 78-92-kD and 96-100-kD proteins of nuclear bodies.

Authors:  M Fusconi; F Cassani; M Govoni; A Caselli; F Farabegoli; M Lenzi; G Ballardini; D Zauli; F B Bianchi
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

Review 6.  Immunoblotting and dot blotting.

Authors:  D I Stott
Journal:  J Immunol Methods       Date:  1989-05-12       Impact factor: 2.303

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.